Zenotech Labs Reports Negative Financial Results for Q1 2024, Receives 'Sell' Rating
Zenotech Laboratories, a microcap pharmaceutical company, reported negative financial results for the quarter ending March 2024. The company's stock has been given a 'Sell' call by MarketsMojo due to a decline in profit before tax, profit after tax, net sales, and operating profit. This is the lowest performance in the last five quarters.
Zenotech Laboratories, a microcap pharmaceutical company, recently announced its financial results for the quarter ending March 2024. According to the report released on May 2, 2024, the company's stock has been given a 'Sell' call by MarketsMOJO.
The financial performance of Zenotech Lab. for the quarter has been negative, with a score of -15 compared to 3 in the previous quarter. This decline can be attributed to several factors, including a decrease in profit before tax (PBT), profit after tax (PAT), and net sales.
The PBT for the quarter was Rs 1.04 crore, which is a significant drop of 66.3% compared to the average PBT of the previous four quarters, which was Rs 3.09 crore. Similarly, the PAT for the quarter was Rs 0.66 crore, a decrease of 76.6% from the average PAT of the previous four quarters, which was Rs 2.83 crore.
The net sales for the quarter were Rs 9.11 crore, a decline of 14.7% from the average net sales of the previous four quarters, which was Rs 10.68 crore. This is also the lowest net sales in the last five quarters, indicating a negative trend in the company's sales.
The operating profit (PBDIT) for the quarter was also at its lowest in the last five quarters, at Rs 2.78 crore. The operating profit margin was also at its lowest, at 30.52%, indicating a decline in the company's efficiency.
The PBT for the quarter was also at its lowest in the last five quarters, at Rs 1.04 crore. The earnings per share (EPS) for the quarter were also at its lowest, at Rs 0.11, indicating a decline in profitability and lower earnings for shareholders.
Overall, the financial results for the quarter ending March 2024 have been negative for Zenotech Laboratories. The company's stock has been given a 'Sell' call by MarketsMOJO, and the near-term trends for PBT, PAT, net sales, and operating profit are all negative.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
